Alyeska Investment Group’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-265,820
Closed -$468K 695
2021
Q1
$468K Sell
265,820
-200,000
-43% -$458K 0.01% 679
2020
Q4
$908K Sell
465,820
-503,727
-52% -$1.06M 0.01% 421
2020
Q3
$2.32M Buy
969,547
+677,001
+231% +$1.86M 0.04% 335
2020
Q2
$857K Buy
+292,546
New +$841K 0.01% 410
2019
Q3
Sell
-585,265
Closed -$2.27M 398
2019
Q2
$2.27M Buy
+585,265
New +$2.58M 0.03% 307
2016
Q1
Sell
-16,077
Closed -$130K 379
2015
Q4
$130K Sell
16,077
-39,866
-71% -$359K ﹤0.01% 365
2015
Q3
$468K Buy
55,943
+5,120
+10% +$47.3K 0.01% 428
2015
Q2
$471K Buy
50,823
+823
+2% +$7.12K 0.01% 454
2015
Q1
$490K Buy
+50,000
New +$504K 0.01% 468

Other funds holding ADMA